SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-041571
Filing Date
2021-08-05
Accepted
2021-08-05 16:03:55
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enta-8k_20210805.htm   iXBRL 8-K 39424
2 EX-99.1 enta-ex991_6.htm EX-99.1 310187
3 GRAPHIC gg12g41vjfma000001.jpg GRAPHIC 5911
  Complete submission text file 0001564590-21-041571.txt   499305

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enta-20210805.xsd EX-101.SCH 5677
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20210805_lab.xml EX-101.LAB 18575
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20210805_pre.xml EX-101.PRE 11029
7 EXTRACTED XBRL INSTANCE DOCUMENT enta-8k_20210805_htm.xml XML 3394
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 211148090
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences